American Journal of Ophthalmology
Volume 147, Issue 5 , Pages 903-906 , May 2009

Sudden Dispersion of Retinoblastoma Shortly after Initial Chemotherapy Treatment

  • Reut Parness-Yossifon

      Affiliations

    • Division of Ophthalmology, Children's Memorial Hospital, Chicago, Illinois
    • Corresponding Author InformationInquiries to Reut Parness-Yossifon, 2300 Children's Plaza, Box 70, Chicago, IL 60614
    • ,
  • Paul J. Bryar

      Affiliations

    • Department of Ophthalmology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Joanna L. Weinstein

      Affiliations

    • Division of Hematology, Oncology, and Transplantation, Children's Memorial Hospital, Chicago, Illinois
    • ,
  • Divya Srikumaran

      Affiliations

    • Department of Ophthalmology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Marilyn B. Mets

      Affiliations

    • Division of Ophthalmology, Children's Memorial Hospital, Chicago, Illinois
    • Department of Ophthalmology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois

,Accepted 9 December 2008.

References 

  1. Balmer A, Zografos L, Munier F. Diagnosis and current management of retinoblastoma. Oncogene. 2006;25:5341–5349
  2. Gallie BL, Budning A, DeBoer G, et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol. 1996;114:1321–1328
  3. Murphree AL, Villablanca JG, Deegan WF, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1348–1356
  4. Shields CL, Honavar SG, Meadows AT, et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol. 2002;133:657–664
  5. Shields CL, Meadows AT, Leahey AM, Shields JA. Continuing challenges in the management of retinoblastoma with chemotherapy. Retina. 2004;24:849–862
  6. Zage PE, Reitman AJ, Seshadri R, et al. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma. Pediatr Blood Cancer. 2008;50:567–572
  7. Tawansy KA, Samuel MA, Shammas M, Murphree AL. Vitreoretinal complications of retinoblastoma treatment. Retina. 2006;26:S47–S52
  8. Shields CL, de Potter P, Himelstein BP, et al. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1330–1338
  9. Shields CL, Hanovar SG, Meadows AT, et al. Chemoreduction for unilateral retinoblastoma. Arch Ophthalmol. 2002;120:1653–1658
  10. Shields CL, Mashayekhi A, Demirci H, et al. Practical approach to management of retinoblastoma. Arch Ophthalmol. 2004;122:729–735
  11. Schouten-van Meeteren AY, van der Valk P, van der Linder HC, et al. Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay. Cancer. 2001;92:2933–2940
  12. Demirci H, Eagle RC, Shields CL, Shields JA. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction. Arch Ophthalmol. 2003;121:1125–1131

PII: S0002-9394(08)00954-9

doi: 10.1016/j.ajo.2008.12.014

American Journal of Ophthalmology
Volume 147, Issue 5 , Pages 903-906 , May 2009

Article Tools

* Image Usage & Resolution